Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 16.03.2026 CPQ IE00BFD2H405 7,750,002.00 USD 366,520,991.58 47.293  ...

LUXEMBOURG--(BUSINESS WIRE)--THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN, OR AT ANY ADDRESS IN, THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 16.03.2026 FDNU IE00BG0SSC32 1,300,002.00 USD 43,635,764.93 33.566  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 16.03.2026 NQCYBREN IE00BF16M727 28,684,076.00 USD 1,126,197,309.46 39.262  ...

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that it will release its audited financial results for the year ended December 31, 2025 before markets open on Thursday, March 26, 2026. Investors and stakeholders are invited to join a live webinar with Joseph Walewicz, NeuPath’s Chief Executive Officer, Stephen Lemieux, NeuPath’s President and in...

MIAMI--(BUSINESS WIRE)--Legends Real Estate Group brings 55 agents, strengthening Real’s presence across Northeast Georgia and the Atlanta metro area....

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the National Comprehensive Cancer Network (NCCN®) has updated its 2026 NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer to include ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary-only diseas...

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced an initiative to expand its reach and complement its existing, telephonic insurance distribution model. SelectQuote Local will leverage the Company’s industry-leading marketing, technology, customer service, and carrier relationships to offer consumers its senior health and life ins...

NEW YORK--(BUSINESS WIRE)--Surf AI, the agentic operations platform for modern security teams, today announced its launch and $57 million in funding to accelerate the development of its AI-native security execution offerings. The round was led by Accel, with participation from existing investors Cyberstarts and Boldstart Ventures. The funding will support continued investment in product development, team expansion, and scaling for additional enterprise adoption. Surf AI was founded in 2024 by a...

DENVER--(BUSINESS WIRE)--Lumen Technologies, Inc. (“Lumen”) (NYSE: LUMN) today announced that Mike Glenn, Chair of Lumen’s Board of Directors (the “Board”), and Hal Stanley Jones, a director and Chair of the Audit Committee, have advised the Board that they will retire and not stand for re-election at Lumen’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). As part of a planned succession process, the Board has selected General Kevin P. Chilton (USAF, Ret.), an existing member of the...